Acceleron axes clinical development of muscular dystrophy drugAcceleron has axed clinical development of its ACE-083 in the inherited muscle-wasting disease muscular dystrophy, after the drug Share XAcceleron axes clinical development of muscular dystrophy drughttps://pharmaphorum.com/news/acceleron-axes-clinical-development-of-muscular-dystrophy-drug/
J&J filing aims Tremfya at crowded psoriatic arthritis marketJohnson & Johnson has filed its IL-23 inhibitor Tremfya for approval in psoriatic arthritis (PsA), its second indication, Share XJ&J filing aims Tremfya at crowded psoriatic arthritis markethttps://pharmaphorum.com/news/jj-filing-aims-tremfya-at-crowded-psoriatic-arthritis-market/
Novartis’ Cosentyx heads for fourth indication after supportive data in early ankylosing spondylitisNovartis’ Cosentyx could be heading for a fourth indication after the company published late-stage trial data showing it Share XNovartis’ Cosentyx heads for fourth indication after supportive data in early ankylosing spondylitishttps://pharmaphorum.com/news/cosentyx-heads-for/
How can biotechnology, pharmaceutical and medical device companies achieve the full potential of content personalisation?By Carlos Casanova Healthcare and life sciences companies have an unrealised opportunity to maximise the benefits of personalising Share XHow can biotechnology, pharmaceutical and medical device companies achieve the full potential of content personalisation?https://pharmaphorum.com/views-analysis-sales-marketing/full-potential-content-personalisation/
Real world evidence, digital partnerships and the future of pharmaAhead of the eyeforpharma Awards we spoke to judge Jennifer Wong – AstraZeneca’s senior director, RWE strategy & Share XReal world evidence, digital partnerships and the future of pharmahttps://pharmaphorum.com/views-analysis-digital/real-world-evidence-digital-partnerships-and-the-future-of-pharma/
Transforming oncology with a pan-European approach to data sharingBetween genomic data, electronic health records and digital health tools, we have all the information we need to Share XTransforming oncology with a pan-European approach to data sharinghttps://pharmaphorum.com/views-analysis-oncology/transforming-oncology-with-a-pan-european-approach-to-data-sharing/
The promise and pitfalls of molecular testing in oncologyGreat strides have been made in the diagnosis and treatment of cancer. However, a variety of challenges remain Share XThe promise and pitfalls of molecular testing in oncologyhttps://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019/research-partnership-molecular-testing-cancer/
Smarter thinking about pharmaceutical marketingRobb DeFilippis, from end-to-end global creative production and sourcing partner Tag, discusses how a more effective multichannel pharma Share XSmarter thinking about pharmaceutical marketinghttps://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019/tag-pharmaceutical-marketing-production/
Getting patients round the virtual tableIf pharma wants to be truly patient-centric, it needs to be talking to patients. This may seem obvious, Share XGetting patients round the virtual tablehttps://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019/impetus-digital-patient-centric-engagement/
Cost & Management of Oncology Combination Regimens Share XCost & Management of Oncology Combination Regimenshttps://pharmaphorum.com/oncology/cost-management-of-oncology-combination-regimens/
Innovative contracting in Europe – a Trojan horse? Share XInnovative contracting in Europe – a Trojan horse?https://pharmaphorum.com/market-access-2/innovative-contracting-in-europe-a-trojan-horse/
How pharma marketing can stay ahead of the evolving customer journey Share XHow pharma marketing can stay ahead of the evolving customer journeyhttps://pharmaphorum.com/digital/how-pharma-marketing-can-stay-ahead-of-the-evolving-customer-journey/
Tell us: how fast is pharma innovatingpharmaphorum is conducting some research into how pharmaceutical marketers are innovating amidst the increasing demands of engaging in Share XTell us: how fast is pharma innovatinghttps://pharmaphorum.com/sales-marketing/tell-us-how-fast-is-pharma-innovating/
How to optimise pharma’s digital HCP engagementPharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if Share XHow to optimise pharma’s digital HCP engagementhttps://pharmaphorum.com/debates-insight-sales-marketing/how-to-optimise-pharmas-digital-hcp-engagement/
A blueprint for healthcare: Brand strategy and planningWhen pharmaceutical and biotech companies are working on their brand strategy and conducting brand planning it is vital Share XA blueprint for healthcare: Brand strategy and planninghttps://pharmaphorum.com/sales-marketing/a-blueprint-for-healthcare-brand-strategy-and-planning/
Building cell therapy leadership in Europe Share XBuilding cell therapy leadership in Europehttps://pharmaphorum.com/video/building-cell-therapy-leadership-europe/
AstraZeneca and lung cancer: the pharmaphorum podcast Share XAstraZeneca and lung cancer: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/astrazeneca-and-lung-cancer
Lung cancer’s patient information gap: the pharmaphorum podcast Share XLung cancer’s patient information gap: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/lung-cancers-patient-information-gap
U.S. Upper Limb Prosthetics Market will touch $544 million by 2025 Share XU.S. Upper Limb Prosthetics Market will touch $544 million by 2025https://pharmaphorum.com/partner-content/u-s-upper-limb-prosthetics-market-will-touch-544-million-by-2025/
Exclusive interview with Novartis industry leader, Maxime Gaillot ahead of Wearable Injectors Share XExclusive interview with Novartis industry leader, Maxime Gaillot ahead of Wearable Injectorshttps://pharmaphorum.com/partner-content/exclusive-interview-with-novartis-industry-leader-maxime-gaillot-ahead-of-wearable-injectors/
Vitamin K Market will reach over $1,000 million by 2025 Share XVitamin K Market will reach over $1,000 million by 2025https://pharmaphorum.com/partner-content/vitamin-k-market-will-reach-over-1000-million-by-2025/
Only two weeks left until the Biobanking 2019 Conference in London Share XOnly two weeks left until the Biobanking 2019 Conference in Londonhttps://pharmaphorum.com/partner-content/only-two-weeks-left-until-the-biobanking-2019-conference-in-london/
Ashfield Commercial and Patient Solutions appoints President of Global Business Development Share XAshfield Commercial and Patient Solutions appoints President of Global Business Developmenthttps://pharmaphorum.com/partner-content/ashfield-commercial-and-patient-solutions-appoints-president-of-global-business-development/
Alice Choi appointed HCA chairperson Share XAlice Choi appointed HCA chairpersonhttps://pharmaphorum.com/news/alice-choi-hca-chairperson/
